Gerresheimer AG - Asset Resilience Ratio
Gerresheimer AG (GXI) has an Asset Resilience Ratio of 0.55% as of May 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Gerresheimer AG carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Gerresheimer AG's Asset Resilience Ratio has changed over time. See net assets of Gerresheimer AG for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Gerresheimer AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see GXI company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €26.00 Million | 0.55% |
| Total Liquid Assets | €26.00 Million | 0.55% |
Asset Resilience Insights
- Limited Liquidity: Gerresheimer AG maintains only 0.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Gerresheimer AG Industry Peers by Asset Resilience Ratio
Compare Gerresheimer AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Gerresheimer AG (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Gerresheimer AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-11-30 | 0.70% | €26.68 Million ≈ $31.19 Million |
€3.81 Billion ≈ $4.45 Billion |
+0.28pp |
| 2023-11-30 | 0.42% | €14.41 Million ≈ $16.85 Million |
€3.43 Billion ≈ $4.01 Billion |
+0.06pp |
| 2022-11-30 | 0.36% | €12.04 Million ≈ $14.08 Million |
€3.35 Billion ≈ $3.92 Billion |
-0.33pp |
| 2021-11-30 | 0.69% | €19.73 Million ≈ $23.07 Million |
€2.88 Billion ≈ $3.36 Billion |
+0.20pp |
| 2020-11-30 | 0.49% | €12.77 Million ≈ $14.93 Million |
€2.62 Billion ≈ $3.06 Billion |
-0.09pp |
| 2019-11-30 | 0.58% | €15.23 Million ≈ $17.80 Million |
€2.64 Billion ≈ $3.09 Billion |
-0.02pp |
| 2018-11-30 | 0.60% | €16.25 Million ≈ $19.00 Million |
€2.73 Billion ≈ $3.19 Billion |
-0.06pp |
| 2017-11-30 | 0.65% | €15.94 Million ≈ $18.64 Million |
€2.44 Billion ≈ $2.86 Billion |
+0.21pp |
| 2016-11-30 | 0.44% | €10.44 Million ≈ $12.21 Million |
€2.37 Billion ≈ $2.78 Billion |
+0.41pp |
| 2015-11-30 | 0.03% | €768.00K ≈ $897.87K |
€2.42 Billion ≈ $2.83 Billion |
-- |
About Gerresheimer AG
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, a… Read more